1. Davis RB, Pahl K, Datto N, Smith SV, Shawber C, Caron KM, Blatt J. Notch expression and gammasecretase inhibitors in human vascular malformations. Scientific Reports. 2018 Dec 20;8(1):17987. doi: 10.1038/s41598-018-36628-1.
  2. Pahl KS, Choudhury A, Wusik K, Hammill A, White A, Henderson K, Pollak J, Kasthuri RS. Applicability of the Curacao Criteria for the diagnosis of hereditary hemorrhagic telangiectasia in the pediatric population. J Pediatr. 2018 Jun;197:207-213. doi: 10.1016/j.jpeds.2018.01.079. Epub 2018 Apr 11

  3. Pahl KS, Kim K, Sams C, Alvarez A, Smith SV, Blatt J. Inconsistency in classifying vascular anomalies: What’s in a name? Pediatr Blood Cancer (2018 Mar;65. doi: 10.1002/pbc.26836. Epub 2017 Oct 8)
  4. Alvarez H, Castillo M. Genetic markers and their influence in cerebrovascular malformations. Neuroimaging clinics of North America. 25 :1 69-82. 2015.
  5. Klein KR and Caron KM 2015 Adrenomedullin in lymphangiogenesis: from development to disease. Cell Mol Life Sci May 8, 2015 Epub ahead of print.
  6. Karpinich NO, Caron KM 2014 Schlemm’s canal: more than meets the eye, lymphatics in disguise. J Clin Invest. 124(9):3701-3.
  7. Karpinich NO, Caron KM 2014 Apelin signaling: new G protein-coupled receptor pathway in lymphatic vascular development. Arterioscler Thromb Vasc Biol. 34:239-41.
  8. Michael R. Jeng, Fuh B, Blatt J, Gupta A, Merrow A, Hammill A, Adams D. Angiosarcoma Due to Transformation of Hepatic Hemangioma: Response to Chemotherapy and Bevacizumab 2014; Pediatr Blood Cancer Apr 17. doi: 10.1002/pbc.25067.
  9. Blatt J, Powell CM, Burkhart CN, Stavas J, Aylsworth AS. Genetics of Hemangiomas, Vascular Malformations, and Primary Lymphedema J Pediatric Hematol Oncol. 2014; 36:587-93.
  10. Alvarez H, Orning J, Castillo M. Orbital vascular lesions : a review of clinical and imaging findings. Expert Rev. Ophtalmol. 8(2), 151-166, 2013
  11. Blatt J, McLean TW, Castellino SM, Burkhart CN. A Review of Contemporary Options for Medical Management of Hemangiomas and Vascular Malformations. Pharmacology and Therapeutics, 2013 139:327- 33.
  12. Blatt J, Morrell D, Buck S, Zdanski C, Stavas J, Gold S, Powell C, Burkhart C. Beta blockers for infantile hemangiomas: A single institution experience. Clin Pediatr 2011; 50:757-763
  13. Blatt J, Stavas J, Moats-Staats B, Woosley J, Morrell DS. Treatment of childhood kaposiform hemangioendothelioma with sirolimus. Pediatr Blood and Cancer 2010; 55:1396-8.
  14. Dunworth W & Caron KM 2009 G protein-coupled receptors as potential drug targets for lymphangiogenesis and lymphatic vascular diseases. Arterioscler Thromb Vascul Biol 29:650-6.
  15. Baccin CE, Krings T, Alvarez H, Ozanne A, Lasjaunias P. A report of two cases with dolichosegmental intracranial arteries as a new feature of PHACES syndrome. Childs Nerv Syst 2007; 23: 559-567.
  16. Gandolfo C, Krings T, Alvarez H, Ozanne A, Schaaf M, Baccin CE, Zhao WY, Lasjaunias P. Sinus pericranii: diagnostic and therapeutic consideration in 15 patients. Neuroradiology 2007; 49: 505-514.
  17. Krings T, Chng SM, Ozanne A, Alvarez H, Rodesch G, Lasjaunias P. Hereditary hemorrhagic telangiectasia in children: endovascular treatment of neurovascular malformations. Neuroradiology 2005; 47: 946-954.
  18. Krings T, Ozanne A, Chng SM, Alvarez H, Rodesch G, Lasjaunias P. Neurovascular phenotypes in hereditary hemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients age 1 day-60 years. Neuroradiology 2005; 47: 711-720.
  19. Krings T, Chng SM, Ozanne A, Alvarez H, Rodesch G, Lasjaunias P. Hereditary hemorrhagic telangiectasia in children. Endovascular treatment of neurovascular malformation. Result in 31 patients Interventional Neuroradiology 2005; 11: 13-23.
  20. Mahadevan J, Ozanne A, Yoshida Y, Weon YC, Alvarez H, Rodesch G, Lasjaunias P. Hereditary hemorrhagic telangiectasia cerebrospinal localization in adults and children. Interventional Neuroradiology 2004; 1: 37-46.
  21. Bhattacharya J, Luo CB, Alvarez H, Rodesch G, Pongpech S, Lasjaunias P. PHACES syndrome: a review of eight previously unreported cases with late arterial occlusions. Neuroradiology 2004; 46: 227-233. Also in: 2005 Year Book of Diagnostic Radiology.
  22. Mohamed Z, Batista L, Sachet M, Mahadevan J, Alvarez H, Lasjaunias P. Growing dural sinus malformation with associated developmental venous anomaly, multiple cavernomas and facial venous malformation in an infant. An associated disease or a disease spectrum? Interventional Neuroradiology 2002; 8: 421-430
  23. Jiarakongmun P, Alvarez H, Rodesch G, Lasjaunias P. Clinical course and angioarchitecture of cerebrofacial arteriovenous metameric syndromes. Interventional Neuroradiology 2002; 8: 251-264.
  24. Bhattacharya JJ, Luo CB, Suh DC, Alvarez H, Rodesch G, Lasjaunias P. Wyburn-Mason or Bonnet-Dechaume-Blanc as cerebrofacial arteriovenous metameric syndromes (CAMS). Interventional Neuroradiology 2001; 7:5.
  25. Blatt J, Woosley JT, Taylor L. Spontaneous remission of multifocal infantile hemangiopericytoma. Med Pediatr Oncol 36:320-322, 2001.
  26. Luo CB, Bhattacharya JJ, Ferreira MS, Alvarez H, Rodesch G, Lasjaunias P. Cerebrofacial vascular disease. Orbit 2000; 22: 89-102.
  27. Rodesch G, Coupre V, Fain J, Alvarez H, Lasjaunias P. Maxillo-mandibular arteriovenous malformations. Endovascular treatment: Report of 14 cases. Rev. Stomatol Chir Maxillofac 1999; 100: 293-298.
  28. Rodesch G, Soupre V, Vazquez MP, Alvarez H, Lasjaunias P. Arteriovenous malformations of the dental arcades. The place of endovascular therapy: Results in 12 cases are presented. Journal of Cranio-maxillofacial Surgery. 1998; 26: 306-313.↑ Top
  29. Rodesch G, Alvarez H, Lasjaunias P. True and Falses Cranio-facial vascular malformations. Ann Péd 1994; 41: 352-362.